The Burden of Cardio-Cerebrovascular Risk Factors: Differences Between Individual Risk and Population Risk

Eduardo Capuano1, Federica Marchese2, Rocco Capuano3

  • 1Department of Cardiology and UTIC, "Gaetano Fucilo Hospital" Mercato S. Severino, Azienda Ospedaliera Universitaria Integrata di Salerno, Salerno, Italy.

Insights

Cardio-cerebrovascular disease risk factors significantly impact major cardiovascular events. Identifying high-impact factors like systolic blood pressure is crucial for effective prevention strategies.

Area of Science:

  • Epidemiology
  • Cardiovascular Medicine
  • Public Health

Background:

  • Cardio-cerebrovascular (CCV) disease poses a major global health challenge, leading to significant mortality and morbidity.
  • Effective mitigation of CCV risk factors is paramount for reducing disease incidence at both individual and population levels.
  • Evidence-based medicine and epidemiological studies are vital for optimizing interventions against CCV disease.

Purpose of the Study:

  • To elucidate the burden of various risk factors in the development of CCV events.
  • To contribute to understanding the etiological role of risk factors in individual patients and the broader community.

Main Methods:

  • A longitudinal survey conducted in 1999 as part of the "VIP (Valle dell'Irno Prevention) Project" collected clinical data and risk factor information.
  • Assessed the incidence of Major Adverse Cardiovascular Events (MACE).
  • Calculated prevalence, absolute risk, odds ratio (OR), additional risk (AR), population attributable risk (PAR), and population attributable risk fraction (PAF) for each risk factor.

Main Results:

  • Significant differences between MACE and non-MACE groups were observed for glomerular filtration rate (GFR), glucose, systolic blood pressure (SBP), BMI, diastolic blood pressure (DBP), cholesterol, triglycerides, creatinine, and uric acid.
  • GFR, glucose, and SBP exhibited the highest Odds Ratios (OR).
  • Systolic blood pressure (29.6%), triglyceridemia (19.4%), and metabolic syndrome (18.3%) demonstrated the greatest population attributable risk fraction (PAF) impact on MACE.

Conclusions:

  • The impact of CCV risk factors on MACE varies significantly when assessed at the individual versus population level.
  • Physicians must consider these distinct perspectives when implementing interventions to reduce CCV events.
Abstract

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
485
Factors affecting Blood pressure01:28

Factors affecting Blood pressure

Several physiological and lifestyle factors influence blood pressure (BP). Understanding these factors is crucial as they are significant in patient education and blood pressure management.
Physiological Factors:
5.5K
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
396
Relative Risk01:12

Relative Risk

Relative risk (RR) is a statistical measure commonly used in epidemiology to compare the likelihood of a particular event occurring between two groups. This metric is important for evaluating the relationship between exposure to a specific risk factor and the probability of a particular outcome. It plays a crucial role in medical research, public health studies, and risk assessment. Relative risk quantifies how much more (or less) likely an event is to occur in an exposed group compared to an...
530
Assessment of the Cardiovascular System I: Subjective Data01:23

Assessment of the Cardiovascular System I: Subjective Data

A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
519
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
200